As of July 1, 2019, the below number of individuals have been recruited in Swedegene. DNA and clinical data collection for these are completed.
|Other allergic reactions||51|
|Cough related to ACE-inhibitors||152|
|Osteonecrosis and atypical fractures due to bisphosphonates||119|
|Phototoxic reactions (mainly due to topical NSAIDs)||50|
|Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs||270|
|Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)||46|
|Hyponatremia/SIADH due to antidepressants and antiepileptics||35|
|CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics||94|
|Stevens-Johnson syndrome/Toxic epidermal necrolysis||63|
|Tendon-rupture from flouroquinolones||25|
|Rhabdomyolysis related to statins/fibrates||51|
|Torsade de Pointes/QT-prolongation||22|
|Narcolepsy associated with Pandemrix||83|
|Bleedings from new oral anticoagulants (NOACs)||60|
|Total number of cases||3140|
ACE = angiotensin converting enzyme; NSAID = non-steroidal anti-inflammatory drug; NOAC=non-vitamin K oral anticoagulant drug.
Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.